Annual Accounts Receivable
$673.10 K
+$48.30 K+7.73%
December 31, 2023
Summary
- As of February 7, 2025, EVOK annual accounts receivable is $673.10 thousand, with the most recent change of +$48.30 thousand (+7.73%) on December 31, 2023.
- During the last 3 years, EVOK annual accounts receivable has risen by +$649.80 thousand (+2788.84%).
- EVOK annual accounts receivable is now at all-time high.
Performance
EVOK Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$2.02 M
+$19.50 K+0.97%
September 30, 2024
Summary
- As of February 7, 2025, EVOK quarterly accounts receivable is $2.02 million, with the most recent change of +$19.50 thousand (+0.97%) on September 30, 2024.
- Over the past year, EVOK quarterly accounts receivable has increased by +$1.35 million (+200.48%).
- EVOK quarterly accounts receivable is now at all-time high.
Performance
EVOK Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
EVOK Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.7% | +200.5% |
| 3 y3 years | +2788.8% | +97.5% |
| 5 y5 years | - | +97.5% |
EVOK Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +128.0% | at high | +585.1% |
| 5 y | 5-year | at high | -100.0% | at high | -100.0% |
| alltime | all time | at high | -100.0% | at high | -100.0% |
Evoke Pharma Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.02 M(+1.0%) |
| Jun 2024 | - | $2.00 M(+38.0%) |
| Mar 2024 | - | $1.45 M(+115.7%) |
| Dec 2023 | $673.10 K(+7.7%) | $673.10 K(-45.4%) |
| Sep 2023 | - | $1.23 M(+20.5%) |
| Jun 2023 | - | $1.02 M(+49.0%) |
| Mar 2023 | - | $687.30 K(+10.0%) |
| Dec 2022 | $624.80 K | $624.80 K(-7.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $675.00 K(+84.6%) |
| Jun 2022 | - | $365.60 K(-12.7%) |
| Mar 2022 | - | $418.90 K(+41.9%) |
| Dec 2021 | $295.20 K(+1167.0%) | $295.20 K(+32.9%) |
| Sep 2021 | - | $222.20 K(+12.0%) |
| Jun 2021 | - | $198.40 K(+55.2%) |
| Mar 2021 | - | $127.80 K(+448.5%) |
| Dec 2020 | $23.30 K(>+9900.0%) | $23.30 K(>+9900.0%) |
| Dec 2019 | $0.00 | $0.00 |
FAQ
- What is Evoke Pharma annual accounts receivable?
- What is the all time high annual accounts receivable for Evoke Pharma?
- What is Evoke Pharma annual accounts receivable year-on-year change?
- What is Evoke Pharma quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Evoke Pharma?
- What is Evoke Pharma quarterly accounts receivable year-on-year change?
What is Evoke Pharma annual accounts receivable?
The current annual accounts receivable of EVOK is $673.10 K
What is the all time high annual accounts receivable for Evoke Pharma?
Evoke Pharma all-time high annual accounts receivable is $673.10 K
What is Evoke Pharma annual accounts receivable year-on-year change?
Over the past year, EVOK annual accounts receivable has changed by +$48.30 K (+7.73%)
What is Evoke Pharma quarterly accounts receivable?
The current quarterly accounts receivable of EVOK is $2.02 M
What is the all time high quarterly accounts receivable for Evoke Pharma?
Evoke Pharma all-time high quarterly accounts receivable is $2.02 M
What is Evoke Pharma quarterly accounts receivable year-on-year change?
Over the past year, EVOK quarterly accounts receivable has changed by +$1.35 M (+200.48%)